Clinical Trial Update: DX-8951f in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of DX-8951f for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DX-8951f

Snippet

Sponsor: Daiichi Sankyo | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED